Laboratory evaluation of the use of cefovecin in healthy dogs

Detalhes bibliográficos
Autor(a) principal: Laposy, Cecília Braga
Data de Publicação: 2014
Outros Autores: Silva, Dheywid Karlos Mattos, Pessoto, Júlia Neves
Tipo de documento: Artigo
Idioma: por
Título da fonte: Semina. Ciências Agrárias (Online)
Texto Completo: https://ojs.uel.br/revistas/uel/index.php/semagrarias/article/view/13831
Resumo: Cefovecin is the third generation semi synthetic cephalosporin. The drug is indicated for treatment of skin and urinary infections. The main difference between cefovecin and the others cephalosporins is the highest plasma protein binding, providing an extend action. Due to lack of laboratory studies demonstrating changes caused by the use of cefovecin, the aim of this study was to evaluate the influence of cefovecin therapy on the serum proteins, hemogram, urea and creatinine activities, blood gas, platelet distribution width (PDW) and platelet count. Ten healthy dogs (males n=4; females n=6), average weight of 10.03±3.54 kg were used. The animals were kept in individual cages all over the experiment. The animals were submitted to the clinical and laboratory examinations as an inclusion criterion for the experiment. Sodium cefovecin (Convenia®) was subcutaneously administered (8mg/ kg) to the dogs. Clinical evaluation and laboratorial analysis was performed prior and at 1, 2, 3, 7, 14 and 21 days post treatment (dpt). Despite to be in accordance with the reference values, it was observed a statistically significant (p<0.05) decrease in total serum protein, globulin, hemoglobin and packed cell volume at 21 dpt. The platelet distribution width (PDW) and platelet count were increased at seven and 21 days (p>0.05), respectively. No changes in urea and creatinine activities, blood gas and leukocyte values were observed in the dogs after the administration of cefovecin. In conclusion, cefovecin can be administered in healthy dogs without causing significant laboratory abnormalities.
id UEL-11_7812656a4630d8a470047fe754a36795
oai_identifier_str oai:ojs.pkp.sfu.ca:article/13831
network_acronym_str UEL-11
network_name_str Semina. Ciências Agrárias (Online)
repository_id_str
spelling Laboratory evaluation of the use of cefovecin in healthy dogsEstudo laboratorial do uso de cefovecina em cães sadiosDogsCefovecinHematologyPlatelet.CãesCefovecinaHematologiaPlaquetas.Patologia ClínicaCefovecin is the third generation semi synthetic cephalosporin. The drug is indicated for treatment of skin and urinary infections. The main difference between cefovecin and the others cephalosporins is the highest plasma protein binding, providing an extend action. Due to lack of laboratory studies demonstrating changes caused by the use of cefovecin, the aim of this study was to evaluate the influence of cefovecin therapy on the serum proteins, hemogram, urea and creatinine activities, blood gas, platelet distribution width (PDW) and platelet count. Ten healthy dogs (males n=4; females n=6), average weight of 10.03±3.54 kg were used. The animals were kept in individual cages all over the experiment. The animals were submitted to the clinical and laboratory examinations as an inclusion criterion for the experiment. Sodium cefovecin (Convenia®) was subcutaneously administered (8mg/ kg) to the dogs. Clinical evaluation and laboratorial analysis was performed prior and at 1, 2, 3, 7, 14 and 21 days post treatment (dpt). Despite to be in accordance with the reference values, it was observed a statistically significant (p<0.05) decrease in total serum protein, globulin, hemoglobin and packed cell volume at 21 dpt. The platelet distribution width (PDW) and platelet count were increased at seven and 21 days (p>0.05), respectively. No changes in urea and creatinine activities, blood gas and leukocyte values were observed in the dogs after the administration of cefovecin. In conclusion, cefovecin can be administered in healthy dogs without causing significant laboratory abnormalities.A cefovecina é a mais nova cefalosporina semissintética de terceira geração, indicada para tratamento de infecções de pele e do trato urinário de cães e gatos. O principal diferencial da cefovecina para as outras cefalosporinas é sua alta ligação às proteínas plasmáticas, o que lhe permite longo período de ação. Devido à ausência de trabalhos demonstrando alterações laboratoriais provocadas pelo uso da cefovecina, este trabalho teve o objetivo de avaliar a influência da terapia com cefovecina sobre as proteínas séricas e suas frações, valores do hemograma, atividade de uréia e creatinina, hemogasometria, distribuição do diâmetro das plaquetas (PDW) e contagem plaquetária em cães hígidos. Foram usados dez cães adultos (machos n=4; fêmeas n=6), com peso médio de 10,03±3,54 Kg, incluídos nos experimento mediante exames clínicos e laboratoriais. Os cães receberam por via subcutânea a cefovecina sódica (Convenia®), na dose de 8mg/Kg e foram acompanhados clínica e laboratorialmente nos dias 1, 2, 3, 7, 14 e 21 após o tratamento (dpt). Apesar de os valores permanecerem dentro da faixa de normalidade para a espécie, houve uma diminuição significativa (P<0,05) nos valores da proteína sérica, globulinas, hemoglobina e volume globular aos 21(dpt). O diâmetro das plaquetas (PDW), bem como sua contagem diminuíram aos 7 e 21 dias, mas sem diferença significativa (P>0,05), respectivamente. Não houve alterações nas atividades de uréia e creatinina, hemogasometria e valores leucocitários após a administração da cefovecina. Conclui-se que a cefovecina pode ser administrada em cães saudáveis sem causar alterações laboratoriais significantes.UEL2014-02-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAvaliado por paresInvestigação laboratorialapplication/pdfhttps://ojs.uel.br/revistas/uel/index.php/semagrarias/article/view/1383110.5433/1679-0359.2014v35n1p365Semina: Ciências Agrárias; Vol. 35 No. 1 (2014); 365-370Semina: Ciências Agrárias; v. 35 n. 1 (2014); 365-3701679-03591676-546Xreponame:Semina. Ciências Agrárias (Online)instname:Universidade Estadual de Londrina (UEL)instacron:UELporhttps://ojs.uel.br/revistas/uel/index.php/semagrarias/article/view/13831/pdf_239Laposy, Cecília BragaSilva, Dheywid Karlos MattosPessoto, Júlia Nevesinfo:eu-repo/semantics/openAccess2015-11-19T18:36:02Zoai:ojs.pkp.sfu.ca:article/13831Revistahttp://www.uel.br/revistas/uel/index.php/semagrariasPUBhttps://ojs.uel.br/revistas/uel/index.php/semagrarias/oaisemina.agrarias@uel.br1679-03591676-546Xopendoar:2015-11-19T18:36:02Semina. Ciências Agrárias (Online) - Universidade Estadual de Londrina (UEL)false
dc.title.none.fl_str_mv Laboratory evaluation of the use of cefovecin in healthy dogs
Estudo laboratorial do uso de cefovecina em cães sadios
title Laboratory evaluation of the use of cefovecin in healthy dogs
spellingShingle Laboratory evaluation of the use of cefovecin in healthy dogs
Laposy, Cecília Braga
Dogs
Cefovecin
Hematology
Platelet.
Cães
Cefovecina
Hematologia
Plaquetas.
Patologia Clínica
title_short Laboratory evaluation of the use of cefovecin in healthy dogs
title_full Laboratory evaluation of the use of cefovecin in healthy dogs
title_fullStr Laboratory evaluation of the use of cefovecin in healthy dogs
title_full_unstemmed Laboratory evaluation of the use of cefovecin in healthy dogs
title_sort Laboratory evaluation of the use of cefovecin in healthy dogs
author Laposy, Cecília Braga
author_facet Laposy, Cecília Braga
Silva, Dheywid Karlos Mattos
Pessoto, Júlia Neves
author_role author
author2 Silva, Dheywid Karlos Mattos
Pessoto, Júlia Neves
author2_role author
author
dc.contributor.author.fl_str_mv Laposy, Cecília Braga
Silva, Dheywid Karlos Mattos
Pessoto, Júlia Neves
dc.subject.por.fl_str_mv Dogs
Cefovecin
Hematology
Platelet.
Cães
Cefovecina
Hematologia
Plaquetas.
Patologia Clínica
topic Dogs
Cefovecin
Hematology
Platelet.
Cães
Cefovecina
Hematologia
Plaquetas.
Patologia Clínica
description Cefovecin is the third generation semi synthetic cephalosporin. The drug is indicated for treatment of skin and urinary infections. The main difference between cefovecin and the others cephalosporins is the highest plasma protein binding, providing an extend action. Due to lack of laboratory studies demonstrating changes caused by the use of cefovecin, the aim of this study was to evaluate the influence of cefovecin therapy on the serum proteins, hemogram, urea and creatinine activities, blood gas, platelet distribution width (PDW) and platelet count. Ten healthy dogs (males n=4; females n=6), average weight of 10.03±3.54 kg were used. The animals were kept in individual cages all over the experiment. The animals were submitted to the clinical and laboratory examinations as an inclusion criterion for the experiment. Sodium cefovecin (Convenia®) was subcutaneously administered (8mg/ kg) to the dogs. Clinical evaluation and laboratorial analysis was performed prior and at 1, 2, 3, 7, 14 and 21 days post treatment (dpt). Despite to be in accordance with the reference values, it was observed a statistically significant (p<0.05) decrease in total serum protein, globulin, hemoglobin and packed cell volume at 21 dpt. The platelet distribution width (PDW) and platelet count were increased at seven and 21 days (p>0.05), respectively. No changes in urea and creatinine activities, blood gas and leukocyte values were observed in the dogs after the administration of cefovecin. In conclusion, cefovecin can be administered in healthy dogs without causing significant laboratory abnormalities.
publishDate 2014
dc.date.none.fl_str_mv 2014-02-27
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Avaliado por pares
Investigação laboratorial
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://ojs.uel.br/revistas/uel/index.php/semagrarias/article/view/13831
10.5433/1679-0359.2014v35n1p365
url https://ojs.uel.br/revistas/uel/index.php/semagrarias/article/view/13831
identifier_str_mv 10.5433/1679-0359.2014v35n1p365
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://ojs.uel.br/revistas/uel/index.php/semagrarias/article/view/13831/pdf_239
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv UEL
publisher.none.fl_str_mv UEL
dc.source.none.fl_str_mv Semina: Ciências Agrárias; Vol. 35 No. 1 (2014); 365-370
Semina: Ciências Agrárias; v. 35 n. 1 (2014); 365-370
1679-0359
1676-546X
reponame:Semina. Ciências Agrárias (Online)
instname:Universidade Estadual de Londrina (UEL)
instacron:UEL
instname_str Universidade Estadual de Londrina (UEL)
instacron_str UEL
institution UEL
reponame_str Semina. Ciências Agrárias (Online)
collection Semina. Ciências Agrárias (Online)
repository.name.fl_str_mv Semina. Ciências Agrárias (Online) - Universidade Estadual de Londrina (UEL)
repository.mail.fl_str_mv semina.agrarias@uel.br
_version_ 1799306068935835648